SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
Research output: Contribution to journal › Article › peer-review
Electronic versions
DOI
| Original language | English |
|---|---|
| Pages (from-to) | 250-255 |
| Journal | Nature Medicine |
| Volume | 23 |
| Issue number | 2 |
| Early online date | 19 Dec 2016 |
| DOIs | |
| Publication status | Published - Feb 2017 |
| Externally published | Yes |